Frontiers in Bioengineering and Biotechnology · 2022 · 58 citations · 42 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyCirculating Tumor CellsImmune Cell InfiltrationNatural Killer Cell BiologyOrgan-on-chip SystemsTumor Immune Microenvironment3D Tumor ModelsImmuno-oncology ModelsModeling Tumor MicroenvironmentOrgan-on-a-chip ModelsOrgan-on-chip PlatformsOrgans-on-chipsTumor Immune Cell InfiltrationTumor Microenvironment Modeling
cell cultures under-represent the complexity and dynamic crosstalk of the tumor microenvironment, animal models do not allow deciphering the anti-tumor activity of the human immune system. Therefore, the development of reliable and predictive preclinical models has become crucial for the screening of immune-therapeutic approaches. We here present an organ-on-chip organ on chips (OOC)-based approach for recapitulating the immune cell Natural Killer (NK) migration under physiological fluid flow, infiltration within a 3D tumor matrix, and activation against neuroblastoma cancer cells in a humanized, fluid-dynamic environment. Circulating NK cells actively initiate a spontaneous "extravasation" process toward the physically separated tumor niche, retaining their ability to interact with matrix-embedded tumor cells, and to display a cytotoxic effect (tumor cell apoptosis). Since NK cells infiltration and phenotype is correlated with prognosis and response to immunotherapy, their phenotype is also investigated: most importantly, a clear decrease in CD16-positive NK cells within the migrated and infiltrated population is observed. The proposed immune-tumor OOC-based model represents a promising approach for faithfully recapitulating the human pathology and efficiently employing the immunotherapies testing, eventually in a personalized perspective. An immune-organ on chip to recapitulate the tumor-mediated infiltration of circulating immune cells within 3D tumor model.
42
Sangeeta N. Bhatia, Donald E. Ingber · Nature Biotechnology · 2014 · 3.2K citations
Estimation of clinical trial success rates and related parameters
Chi Heem Wong, Kien Wei Siah, Andrew W. Lo · Biostatistics · 2017 · 1.5K citations · Full text
Medicine, Biostatistics, Oncology +10
Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells
Roberta Castriconi, Alessandra Dondero, Maria Valeria Corrias et al. · Cancer Research · 2004 · 252 citations · Full text
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
Andrea Pavesi, Anthony T. Tan, Sarene Koh et al. · JCI Insight · 2017 · 241 citations · Full text
Medicine, Immunology, Oncology +17